1 Judge Stays Abortion Drug’s Approval; Another Enjoins Any FDA Change To Status
Two federal courts on April 7 issued conflicting orders regarding the availability of the abortion drug mifepristone, with a Texas judge staying the Food and Drug Administration’s 23-year-old approval of the...To view the full article, register now.
Already a subscriber? Click here to view full article